NO813140L - Fremgangsmaate ved fremstilling av ringaapne nucleosidanaloger - Google Patents
Fremgangsmaate ved fremstilling av ringaapne nucleosidanalogerInfo
- Publication number
- NO813140L NO813140L NO813140A NO813140A NO813140L NO 813140 L NO813140 L NO 813140L NO 813140 A NO813140 A NO 813140A NO 813140 A NO813140 A NO 813140A NO 813140 L NO813140 L NO 813140L
- Authority
- NO
- Norway
- Prior art keywords
- annual
- procedure
- preparation
- nucleoside analogs
- nucleoside
- Prior art date
Links
- 239000002777 nucleoside Substances 0.000 title 1
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/187,631 US4347360A (en) | 1980-09-16 | 1980-09-16 | Ring open nucleoside analogues |
Publications (3)
Publication Number | Publication Date |
---|---|
NO813140L true NO813140L (no) | 1982-03-17 |
NO161739B NO161739B (no) | 1989-06-12 |
NO161739C NO161739C (no) | 1989-09-20 |
Family
ID=22689793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO813140A NO161739C (no) | 1980-09-16 | 1981-09-15 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin- og pyrimidinforbindelser. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4347360A (no) |
EP (2) | EP0049072B1 (no) |
JP (1) | JPS5785373A (no) |
AR (1) | AR228756A1 (no) |
AU (1) | AU546840B2 (no) |
CA (1) | CA1305137C (no) |
CS (1) | CS258109B2 (no) |
DE (1) | DE3177156D1 (no) |
DK (1) | DK411081A (no) |
ES (1) | ES8206488A1 (no) |
FI (1) | FI72977C (no) |
HK (1) | HK82292A (no) |
IE (1) | IE58275B1 (no) |
IL (1) | IL63832A (no) |
MX (1) | MX7299E (no) |
NO (1) | NO161739C (no) |
PT (1) | PT73678B (no) |
SG (1) | SG74392G (no) |
YU (1) | YU224281A (no) |
ZA (1) | ZA816389B (no) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4501744A (en) * | 1980-09-16 | 1985-02-26 | Ens Bio Logicals Inc. | Substituted-aza-cytosine compounds and anti-viral uses thereof |
US5157120A (en) * | 1980-09-16 | 1992-10-20 | Syntex (U.S.A.) Inc. | Guanine derivatives |
US4508898A (en) * | 1980-09-16 | 1985-04-02 | Ogilvie Kelvin K | Antiviral triazine compounds |
US4355032B2 (en) * | 1981-05-21 | 1990-10-30 | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
US4423050A (en) * | 1981-05-21 | 1983-12-27 | Syntex (U.S.A.) Inc. | 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent |
DE3278501D1 (en) * | 1981-08-11 | 1988-06-23 | Wellcome Found | Antiviral compounds |
NZ201662A (en) * | 1981-08-26 | 1986-07-11 | Merck & Co Inc | 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation |
US5250535A (en) * | 1982-02-01 | 1993-10-05 | Syntex Inc. | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent |
US4902678A (en) * | 1982-02-12 | 1990-02-20 | Syntex (U.S.A.) Inc. | Anti-viral compositions |
US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
US4609661A (en) * | 1982-08-09 | 1986-09-02 | Syntex (U.S.A.) Inc. | Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents |
IE55921B1 (en) * | 1982-09-17 | 1991-02-27 | Glaxo Group Ltd | 5-halovinyl-2'-deoxyuridine derivatives |
NO833526L (no) * | 1982-09-30 | 1984-04-02 | Syntex Inc | Fremgangsmaate for fremstilling av guanidinderivater med anti-virus-virkning |
US4609662A (en) * | 1982-10-14 | 1986-09-02 | Burroughs Wellcome Co. | Method for using purine derivatives |
US4462986A (en) * | 1982-11-04 | 1984-07-31 | Ens Bio Logicals, Inc. | Synergistic anti-herpes compositions |
US4565868A (en) * | 1983-02-07 | 1986-01-21 | Syntex (U.S.A.) Inc. | Process for preparing guanine derivatives |
US4460690A (en) * | 1983-02-18 | 1984-07-17 | Ens Bio Logicals Inc. | Stimulation of viral growth rate |
US4461757A (en) * | 1983-02-23 | 1984-07-24 | Ens Bio Logicals Inc. | Dimethylaminomethylenated anti-herpes compounds |
US5047533A (en) * | 1983-05-24 | 1991-09-10 | Sri International | Acyclic purine phosphonate nucleotide analogs |
DE3490262T1 (de) * | 1983-05-24 | 1985-11-28 | Sri International, Menlo Park, Calif. | Antivirus-Mittel |
US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
US4670424A (en) * | 1983-09-19 | 1987-06-02 | Merck & Co., Inc. | Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides |
US4897479A (en) * | 1983-09-30 | 1990-01-30 | Merck & Co., Inc. | Arylsulfonyloxy purine intermediates |
US4918219A (en) * | 1983-10-31 | 1990-04-17 | Warner-Lambert Company | Glycerine derivatives |
US4806642A (en) * | 1984-10-05 | 1989-02-21 | Warner-Lambert Company | Purine derivatives |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
US4579849A (en) * | 1984-04-06 | 1986-04-01 | Merck & Co., Inc. | N-alkylguanine acyclonucleosides as antiviral agents |
DE3585643D1 (de) * | 1984-07-03 | 1992-04-23 | Wellcome Found | Antiviren-verbindungen, behandlung und formulierungen. |
EP0190123A1 (en) * | 1984-07-20 | 1986-08-13 | GAUNTT, Charles, O. | Immunoregulatory and anti-viral compound |
CS263951B1 (en) * | 1985-04-25 | 1989-05-12 | Antonin Holy | 9-(phosponylmethoxyalkyl)adenines and method of their preparation |
MY101126A (en) * | 1985-12-13 | 1991-07-31 | Beecham Group Plc | Novel compounds |
CA1330794C (en) * | 1987-03-27 | 1994-07-19 | Phillip Frost | Anti-viral compounds, dosage forms and methods |
US4863927A (en) * | 1987-05-11 | 1989-09-05 | Merck & Co., Inc. | 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils |
JPH0819111B2 (ja) * | 1987-10-22 | 1996-02-28 | ポーラ化成工業株式会社 | 2―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤 |
ZA892407B (en) * | 1988-03-31 | 1989-11-29 | Mitsubishi Chem Ind | 6-substituted acyclopyrimidine nucleoside derivative and antiviral agent containing the same as active ingredient thereof |
US5246931A (en) * | 1988-10-25 | 1993-09-21 | Bristol-Myers Squibb Company | Carbocyclic nucleoside analogs |
GB8829571D0 (en) * | 1988-12-19 | 1989-02-08 | Wellcome Found | Antiviral compounds |
EP0375329B1 (en) * | 1988-12-19 | 1995-05-31 | The Wellcome Foundation Limited | Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them |
CA2009110A1 (en) * | 1989-02-02 | 1990-08-02 | Richard L. Tolman | Cyclic monophosphates of purine and pyrimidine acyclonucleosides |
DE3906357A1 (de) * | 1989-03-01 | 1990-09-06 | Boehringer Mannheim Gmbh | Neue acyclische nucleosid-analoga, verfahren zu ihrer herstellung und verwendung dieser verbindungen als antivirale arzneimittel |
DE4020481A1 (de) * | 1990-06-27 | 1992-01-02 | Hoechst Ag | Verfahren zur herstellung von substituierten acyclischen nukleosiden und dabei auftretende zwischenprodukte |
US5068119A (en) * | 1990-09-28 | 1991-11-26 | Nabisco Brands, Inc. | Acid-hydrolyzable ester derivatives as low calorie fat mimetics |
US5532225A (en) * | 1992-07-31 | 1996-07-02 | Sri International | Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods |
US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
WO1999057120A1 (en) | 1998-05-04 | 1999-11-11 | Neotherapeutics, Inc. | Novel serotonin-like 9-substituted hypoxanthine and methods of use |
US6297226B1 (en) | 1999-10-15 | 2001-10-02 | Neotherapeutics, Inc. | Synthesis and methods of use of 9-substituted guanine derivatives |
US6407237B1 (en) | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
US6849735B1 (en) | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
AU2001271908A1 (en) | 2000-07-07 | 2002-01-21 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
WO2007065231A2 (en) * | 2005-12-08 | 2007-06-14 | K.U. Leuven Research & Development | Azacytosine derivatives useful as antiviral agents |
US20090203636A1 (en) * | 2006-03-14 | 2009-08-13 | Bondarev Igor E | Prevention and Treatment of Cancer and Other Diseases |
JP5932829B2 (ja) | 2010-12-10 | 2016-06-08 | シグマファーム ラボラトリーズ エルエルシー | 経口活性ヌクレオチドアナログ又は経口活性ヌクレオチドアナログプロドラッグの高度に安定な組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
US4146715A (en) * | 1975-08-27 | 1979-03-27 | Burroughs Wellcome Co. | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
JPS52105195A (en) * | 1976-03-01 | 1977-09-03 | Wellcome Found | Substituted purine |
US4158056A (en) * | 1978-07-13 | 1979-06-12 | Eli Lilly And Company | Antiviral method |
US4355032B2 (en) * | 1981-05-21 | 1990-10-30 | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
DE3278501D1 (en) * | 1981-08-11 | 1988-06-23 | Wellcome Found | Antiviral compounds |
NZ201662A (en) * | 1981-08-26 | 1986-07-11 | Merck & Co Inc | 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation |
-
1980
- 1980-09-16 US US06/187,631 patent/US4347360A/en not_active Expired - Lifetime
-
1981
- 1981-09-14 FI FI812857A patent/FI72977C/fi not_active IP Right Cessation
- 1981-09-14 IL IL63832A patent/IL63832A/xx not_active IP Right Cessation
- 1981-09-15 DK DK411081A patent/DK411081A/da not_active Application Discontinuation
- 1981-09-15 IE IE214081A patent/IE58275B1/en not_active IP Right Cessation
- 1981-09-15 PT PT73678A patent/PT73678B/pt unknown
- 1981-09-15 AR AR286777A patent/AR228756A1/es active
- 1981-09-15 EP EP81304227A patent/EP0049072B1/en not_active Expired - Lifetime
- 1981-09-15 EP EP87104286A patent/EP0243670B1/en not_active Expired - Lifetime
- 1981-09-15 MX MX819671U patent/MX7299E/es unknown
- 1981-09-15 DE DE8181304227T patent/DE3177156D1/de not_active Expired - Lifetime
- 1981-09-15 ES ES505491A patent/ES8206488A1/es not_active Expired
- 1981-09-15 NO NO813140A patent/NO161739C/no unknown
- 1981-09-15 ZA ZA816389A patent/ZA816389B/xx unknown
- 1981-09-16 CS CS816832A patent/CS258109B2/cs unknown
- 1981-09-16 JP JP56144801A patent/JPS5785373A/ja active Granted
- 1981-09-16 CA CA000386013A patent/CA1305137C/en not_active Expired - Lifetime
- 1981-09-16 AU AU75273/81A patent/AU546840B2/en not_active Expired
- 1981-09-16 YU YU02242/81A patent/YU224281A/xx unknown
-
1992
- 1992-07-20 SG SG743/92A patent/SG74392G/en unknown
- 1992-10-22 HK HK822/92A patent/HK82292A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO161739B (no) | 1989-06-12 |
YU224281A (en) | 1983-10-31 |
DE3177156D1 (de) | 1990-03-08 |
FI72977B (fi) | 1987-04-30 |
AU546840B2 (en) | 1985-09-26 |
MX7299E (es) | 1988-04-27 |
FI72977C (fi) | 1987-08-10 |
US4347360A (en) | 1982-08-31 |
US4347360B1 (no) | 1985-10-08 |
DK411081A (da) | 1982-03-17 |
CS683281A2 (en) | 1987-08-13 |
JPS5785373A (en) | 1982-05-28 |
IE812140L (en) | 1982-03-16 |
CS258109B2 (en) | 1988-07-15 |
CA1305137C (en) | 1992-07-14 |
ES505491A0 (es) | 1982-08-16 |
HK82292A (en) | 1992-10-30 |
IE58275B1 (en) | 1993-08-25 |
IL63832A0 (en) | 1981-12-31 |
ES8206488A1 (es) | 1982-08-16 |
FI812857L (fi) | 1982-03-17 |
SG74392G (en) | 1992-10-02 |
EP0243670B1 (en) | 1992-07-22 |
AR228756A1 (es) | 1983-04-15 |
PT73678A (en) | 1981-10-01 |
EP0049072B1 (en) | 1990-01-31 |
NO161739C (no) | 1989-09-20 |
IL63832A (en) | 1985-06-30 |
ZA816389B (en) | 1982-09-29 |
AU7527381A (en) | 1982-03-25 |
PT73678B (en) | 1983-10-20 |
EP0049072A1 (en) | 1982-04-07 |
JPH052671B2 (no) | 1993-01-13 |
EP0243670A1 (en) | 1987-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO813140L (no) | Fremgangsmaate ved fremstilling av ringaapne nucleosidanaloger | |
NO813339L (no) | R fremgangsmaate ved fremstilling av substituerte iminodisyre | |
NO810358L (no) | Fremgangsmaate ved fremstilling av antihypercholesterolemiske | |
NO781082L (no) | Fremgangsmaate ved fremstilling av jodofore forbindelser | |
NO811731L (no) | Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater | |
NO813678L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
NO801155L (no) | Fremgangsmaate ved fremstilling av acyl-carnitinamider | |
IT1133075B (it) | Procedimento per la preparazione della monacolina k | |
ES498980A0 (es) | Procedimiento para la preparacion de compuestos de quinazo- lina cromogenos | |
NO814065L (no) | Fremgansmaate for fremstilling av imidazolylfenylamidiner | |
NO830988L (no) | Fremgangsmaate ved fremstilling av stabiliserte pge-derivater | |
NO773682L (no) | Fremgangsmaate ved fremstilling av furocumariner | |
DK156099C (da) | Fremgangsmaade ved fremkaldelse | |
DK392380A (da) | Fremgangsmaade til fremstilling af olefiniske dobbeltbindinger ved halogenbrintefraspaltning | |
NO813814L (no) | Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser | |
ES500752A0 (es) | Procedimiento para la preparacion de terpolimeros acrilicos | |
NO853468L (no) | Fremgangsmaate ved fremstilling av 6-substituerte mitomycinanaloger. | |
NO813477L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
NO812467L (no) | Fremgangsmaate ved fremstilling av as-triazinderivater | |
IT8049274A0 (it) | Procedimento per la preparazione dicomposti azobenzenici(caso 150-4345) | |
ES502120A0 (es) | Procedimiento para la preparacion de compuestos de viniles- tilbeno | |
NO831445L (no) | Fremgangsmaate for deemulgering ved hjelp av ammonium-polyamidoaminer | |
MX6936E (es) | Procedimiento para la preparacion de compuestos derivados de triazol | |
NO148590C (no) | Fremgangsmaate ved fremstilling av natriumperkarbonat | |
ES500959A0 (es) | Procedimiento para la preparacion de derivados de cianoal- quil-fenilurea |